Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia

NCT01829711 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia, Hairy Cell

Interventions

DRUG: Moxetumomab pasudotox
DRUG: IV Bag Protectant for Moxetumomab pasudotox

Sponsor

MedImmune LLC